p53 and disease: when the guardian angel fails (Q36430165)

14 August 2017

1 reference

title

p53 and disease: when the guardian angel fails (English)

1 reference

14 August 2017

Royds JA

1

1 reference

14 August 2017

Iacopetta B

series ordinal

2

1 reference

14 August 2017

publication date

1 June 2006

1 reference

Cell Death & Differentiation

14 August 2017

published in

1 reference

14 August 2017

volume

13

1 reference

14 August 2017

issue

6

1 reference

14 August 2017

page(s)

1017-1026

1 reference

Strategies for therapeutic targeting of the p53 pathway in cancer.

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401913

Cancer. p53, guardian of the genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401913

A single nucleotide polymorphism in the MDM2 gene: from a molecular and cellular explanation to clinical effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401913

Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401913

Incidence of germ-line p53 mutations in patients with gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401913

Germline TP53 mutations and Li-Fraumeni syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401913

Germline p53 mutations in a cohort with childhood sarcoma: sex differences in cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401913

P53 germline mutations in childhood cancers and cancer risk for carrier individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401913

Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401913

Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401913

DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401913

Early onset brain tumor and lymphoma in MSH2-deficient children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401913

Li-Fraumeni syndrome: a p53 family affair

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401913

Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401913

Li-Fraumeni syndrome – a molecular and clinical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401913

Two metachronous tumors in the radiotherapy fields of a patient with Li-Fraumeni syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401913

Age-dependent prognostic effects of genetic alterations in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401913

Suppression of alternative lengthening of telomeres by Sp100-mediated sequestration of the MRE11/RAD50/NBS1 complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401913

Activation of the ALT pathway for telomere maintenance can affect other sequences in the human genome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401913

Alternative lengthening of telomeres and survival in patients with glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401913

Expression of cytokines and transcription factors in photocoagulated human retinal pigment epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401913

Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low-oxygen conditions is independent of p53 status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401913

The role of p53 in hypoxia-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401913

Nuclear and mitochondrial apoptotic pathways of p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401913

Hypoxia death stimulus induces translocation of p53 protein to mitochondria. Detection by immunofluorescence on whole cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401913

The corepressor mSin3a interacts with the proline-rich domain of p53 and protects p53 from proteasome-mediated degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401913

Transcriptional repression of the anti-apoptotic survivin gene by wild type p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401913

The IARC TP53 database: new online mutation analysis and recommendations to users

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401913

Reassessment of the TP53 mutation database in human disease by data mining with a library of TP53 missense mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401913

Significance of TP53 mutations in human cancer: a critical analysis of mutations at CpG dinucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401913

The TP53 colorectal cancer international collaborative study on the prognostic and predictive significance of p53 mutation: influence of tumor site, type of mutation, and adjuvant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401913

Somatic mutations in the p53 gene and prognosis in breast cancer: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401913

An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401913

Mutations in residues of TP53 that directly contact DNA predict poor outcome in human primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401913

21 January 2018

Surfing the p53 network

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401913

Understanding the function-structure and function-mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401913

Disruption of p53 in human cancer cells alters the responses to therapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401913

p53 alterations are predictive of chemoresistance and aggressiveness in ovarian carcinomas: a molecular and immunohistochemical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401913

Stimulation of vascular smooth muscle cell migration by macrophage migration inhibitory factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401913

The p53-dependent effects of macrophage migration inhibitory factor revealed by gene targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401913

Oxidative stress and ulcerative colitis-associated carcinogenesis: studies in humans and animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401913

NF-kappaB functions as a tumour promoter in inflammation-associated cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401913

The antioxidant function of the p53 tumor suppressor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401913

Endothelial apoptosis induced by oxidative stress through activation of NF-kappaB: antiapoptotic effect of antioxidant agents on endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401913

Overexpression of p73 causes apoptosis in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401913

Macrophage-specific p53 expression plays a crucial role in atherosclerosis development and plaque remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401913

p53 inhibitors preserve dopamine neurons and motor function in experimental parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401913

ATM: the product of the gene mutated in ataxia-telangiectasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401913

Aprataxin, a novel protein that protects against genotoxic stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401913

Proteomics for the early detection and treatment of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401913

Modulation of age at onset of Huntington disease patients by variations in TP53 and human caspase activated DNase (hCAD) genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401913

tumor suppressor p53 binds with high affinity to CTG.CAG trinucleotide repeats and induces topological alterations in mismatched duplexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401913

21 January 2018

The Li-Fraumeni syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401913

7 January 2021

Significance of intron 6 sequence variations in the TP53 gene in Li-Fraumeni syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401913

7 January 2021

World Health Organization classification of tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401913

7 January 2021

Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401913

7 January 2021

Transcription of human cathepsin B is mediated by Sp1 and Ets family factors in glioma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401913

7 January 2021

Concordance between p53 protein overexpression and gene mutation in a large series of common human carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401913

7 January 2021

Lack of correlation between p53-dependent transcriptional activity and the ability to induce apoptosis among 179 mutant p53s

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401913

7 January 2021

Detection of p53 gene mutation by rapid PCR-SSCP and its association with poor survival in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401913

7 January 2021

Prognostic value of TP53 gene mutation in adjuvant treated breast cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401913

7 January 2021

Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401913

7 January 2021

P53 abnormalities and outcomes in colorectal cancer: a systematic review.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401913

7 January 2021

p53 is a suppressor of inflammatory response in mice.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401913

7 January 2021

Expression of c-fos, p53 and PCNA in the unstable atherosclerotic carotid plaque

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401913

7 January 2021

The absence of p53 accelerates atherosclerosis by increasing cell proliferation in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401913

7 January 2021

p53 tumor suppressor protein regulates the levels of huntingtin gene expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401913

7 January 2021

Identifiers

DOI

10.1038/SJ.CDD.4401913

1 reference

14 August 2017

1 reference